Criteo vs Stagwell
CRTO and STGW side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRTO and STGW compare
Stagwell is the larger company, worth 3.6 times as much as Criteo ($2.6B against $718M).
On earnings, Criteo is cheaper: it trades at 5.5× trailing earnings, against 262× for Stagwell.
Stagwell grew revenue faster over the last twelve months (7.7% versus 0.60% for Criteo).
Criteo keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with 0.31% at Stagwell.
Criteo scores higher on the StockData Score (19 against 5 for Stagwell), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRTO | STGW |
|---|---|---|
| Size and price | ||
| Market cap | $718M | $2.6B |
| Share price | $14.65 | $10.47 |
| Change, 1 year | −33.9% | 120% |
| Change, 5 years | −64.0% | −1.3% |
| Beta (5Y) | 0.79 | 1.29 |
| Employees | 1,181 | 11K |
| StockData Score | ||
| Total score | 19 (better) | 5 |
| Valuation score | 6 (better) | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 2 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 5.5× (better) | 262× |
| P/S | 0.4× (better) | 0.8× |
| P/B | 0.6× (better) | 3.7× |
| EV/EBITDA | 2.3× (better) | 12.6× |
| P/FCF | 3.4× (better) | 7.0× |
| PEG | 0.03 | – |
| FCF yield | 29.0% (better) | 14.4% |
| Fair value | $53.15 | $6.26 |
| Margin of safety | 72.4% (better) | −67.2% |
| Growth | ||
| Revenue growth (TTM) | 0.60% | 7.7% (better) |
| Revenue growth, 5Y average | −1.3% | 26.8% (better) |
| Net income growth (TTM) | 29.6% (better) | −50.8% |
| EPS growth (TTM) | 38.9% (better) | −33.3% |
| EPS growth, 5Y average | 17.9% | – |
| Profitability | ||
| Gross margin | 54.0% (better) | 36.0% |
| Operating margin | 10.4% (better) | 4.0% |
| Net margin | 7.4% (better) | 0.31% |
| FCF margin | 10.7% | 11.8% (better) |
| Return on equity | 13.0% (better) | 1.3% |
| Return on invested capital | 17.4% (better) | 3.1% |
| Financial health | ||
| Debt / equity | 0.00 | 2.04 (better) |
| Net debt / EBITDA | – | 4.19 |
| Interest coverage | 82.4× | – |
| Current ratio | 1.29 (better) | 0.81 |
| Altman Z-score | 2.35 (better) | 1.21 |
| Piotroski F-score | 9 (better) | 6 |
| Dividends and buybacks | ||
| Buyback yield | 21.2% (better) | 4.7% |
| Shareholder yield | 21.2% (better) | 4.7% |
| Ownership | ||
| Held by institutions | 83.9% | 43.1% |
| Held by insiders | 4.0% | – |
| Insider net buying, 12 months | −$1.5M (better) | −$13.5M |
| Short interest, % of float | 2.4% | – |
Go deeper
- CRTO stock overview
- CRTO income statement
- CRTO valuation and score
- STGW stock overview
- STGW income statement
- STGW valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.